Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02515110 · ClinicalTrials.gov registry record · NA
Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer
A NA study of Breast Cancer and Invasive Breast Carcinoma, sponsored by Virginia Commonwealth University.
- Active
- Registry status
- NA
- Development phase
- 137
- Enrollment target
- 2
- Study locations
NCT02515110 is a NA study of Breast Cancer and Invasive Breast Carcinoma that is active but no longer recruiting, run by Virginia Commonwealth University. The registered enrollment target is 137 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02515110, a NA study of Breast Cancer and Invasive Breast Carcinoma, is active but no longer recruiting, sponsored by Virginia Commonwealth University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
- 2
- Study locations
Study Summary
Single-arm, phase 2 study evaluating hypofractionated irradiation of breast and regional nodes in women with breast cancer. Patients will be grouped in 3 surgery-related treatment groups: 1) An intact breast following lumpectomy; 2) plans for loco regional external beam radiotherapy (EBRT) following mastectomy (with or without plans for reconstruction); and 3) plans for locoregional EBRT following mastectomy with reconstruction. Patients will be assessed for lymphedema, arm function, breast or chestwall pain, other EBRT-related adverse events, and, for patients who had a lumpectomy or mastectomy with reconstruction, cosmetic outcome.
Conditions Studied
Interventions
- RADIATION External Beam Radiation Therapy
Study Locations (2)
Virginia
- Virginia Commonwealth University/Massey Cancer Center - Richmond
- VCU Community Memorial Healthcenter - South Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2015-08-04 |
| Est. Completion | 2028-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02515110
The ClinicalTrials.gov registry entry for NCT02515110 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which External Beam Radiation Therapy is the first listed.
NCT02515110 reports 2 study locations spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT02515110 about?
NCT02515110 is a clinical study titled "Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer". Single-arm, phase 2 study evaluating hypofractionated irradiation of breast and regional nodes in women with breast cancer. Patients will be grouped in 3 surgery-related treatment groups: 1) An intact breast following lumpectomy; 2) plans for loco regional external beam radiotherapy (EBRT) following...
What is the current status of trial NCT02515110?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 137 participants. The study started on 2015-08-04. Estimated completion is 2028-04-30.
What conditions does trial NCT02515110 study?
This clinical trial studies the following conditions: Breast Cancer, Invasive Breast Carcinoma, Breast Adenocarcinoma, Lobular Breast Carcinoma in Situ, Node-positive Breast Cancer.
What interventions are being tested in trial NCT02515110?
The interventions under investigation include: External Beam Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT02515110?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02515110 being conducted?
This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.